Accounting for the effect of GERD symptoms on patients' health-related quality of life: Supporting optimal disease management by primary care physicians

International Journal of Clinical Practice

Volumn 61, Issue 12, 2007, Pages 2071-2078

  Flook, N W ^a   Wiklund, I ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ASTRAZENECA R AND D   (Sweden)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; RANITIDINE;

ACCOUNTING; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DOCTOR PATIENT RELATION; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM RATING SCALE; GERD IMPACT SCALE; HUMAN; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE IN REFLUX AND DYSPEPSIA; QUESTIONNAIRE; RATING SCALE; REFLUX DISEASE QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SHORT FORM 36; TREATMENT PLANNING;

COMMUNICATION; GASTROESOPHAGEAL REFLUX; HUMANS; NEEDS ASSESSMENT; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 35948965932     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01586.x     Document Type: Review

References (49)

1. Dent J, El-Serag HB, Wallander MA et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005 54 : 710 7.
2. Jones R. Gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol Suppl 1995 211 : 35 8.
3. McDougall NI, Johnston BT, Kee F et al. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996 38 : 481 6.
4. Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med 1999 72 : 93 100.
5. Thomson AB, Barkun AN, Armstrong D et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003 17 : 1481 91.
6. Armstrong D, Marshall JK, Chiba N et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol 2005 19 : 15 35.
7. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
8. Dent J, Armstrong D, Delaney B et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004 53 (Suppl. 4 iv1 24.
9. Fock KM, Talley N, Hunt R et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004 19 : 357 67.
10. Vakil N, Veldhuyzen van Zanten S, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 20.
11. Veldhuyzen van Zanten S, Armstrong D, Barkun A et al. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire. Aliment Pharmacol Ther 2007 25 : 1087 97.
12. Fass R, Achem SR, Harding S et al. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux. Aliment Pharmacol Ther 2004 20 (Suppl. 9 26 38.
13. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004 22 : 108 14.
14. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989 27 (3 Suppl. S217 32.
15. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 : 473 83.
16. Dupuy HJ. The psychological general well being index. In : Wenger NK, Mattson ME, Furberg CF et al., eds. Assessment of Quality of Life in Clinical Trails of Cardiovascular Therapies. Darien, CT : Le Jacq Communications Inc., 1984 : 170 83.
17. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990 16 : 199 208.
18. Wiklund IK, Junghard O, Grace E et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998 583 : 41 9.
19. Svedlund J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988 33 : 129 34.
20. Shaw MJ, Talley NJ, Beebe TJ et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001 96 : 52 7.
21. Jones R, Coyne K, Wiklund I. The Gastro-oesophageal Reflux Disease Impact Scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007 25 : 1451 9.
22. Revicki DA, Wood M, Wiklund I et al. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 1998 7 : 75 83.
23. Kulig M, Leodolter A, Vieth M et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003 18 : 767 76.
24. Kaplan-Machlis B, Spiegler GE, Revicki DA. Health-related quality of life in primary care patients with gastroesophageal reflux disease. Ann Pharmacother 1999 33 : 1032 6.
25. Liker H, Hungin P, Wiklund I. Managing gastroesophageal reflux disease in primary care: the patient perspective. J Am Board Fam Pract 2005 18 : 393 400.
26. Johnson DA. Gastroesophageal reflux disease and sleep disorders: a wake-up call for physicians and their patients. Rev Gastroenterol Disord 2005 5 (Suppl. 2 S3 11.
27. National Heartburn Alliance. National Heartburn Alliance Survey 2000 Results: A Community Perspective. Chicago : National Heartburn Alliance, 2000.
28. Shaker R, Castell DO, Schoenfeld PS et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003 98 : 1487 93.
29. Farup C, Kleinman L, Sloan S et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001 161 : 45 52.
30. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006 101 : 18 28.
31. Junghard O, Carlsson R, Lind T. Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials. Scand J Gastroenterol 2003 38 : 1197 9.
32. Hunt RH. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995 9 (Suppl. 1 3 7.
33. Revicki DA, Sorensen S, Maton PN et al. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis 1998 16 : 284 91.
34. Havelund T, Lind T, Wiklund I et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999 94 : 1782 9.
35. Johanson JF, Siddique R, Damiano AM et al. Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease. Dig Dis Sci 2002 47 : 2574 8.
36. Damiano A, Siddique R, Xu X et al. Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole. Dig Dis Sci 2003 48 : 657 62.
37. Pare P, Armstrong D, Pericak D et al. Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine. J Clin Gastroenterol 2003 37 : 132 8.
38. Revicki DA, Zodet MW, Joshua-Gotlib S et al. Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Health Qual Life Outcomes 2003 1 : 73.
39. Johnson DA, Orr WC, Crawley JA et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol 2005 100 : 1914 22.
40. de Souza Cury M, Ferrari AP, Ciconelli R et al. Evaluation of health-related quality of life in gastroesophageal reflux disease patients before and after treatment with pantoprazole. Dis Esophagus 2006 19 : 289 93.
41. Hansen ÅN, Bergheim R, Fagertun H et al. Long-term management of patients with symptoms of gastro-oesophageal reflux disease - a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting. Int J Clin Pract 2006 60 : 15 22.
42. Ponce J, Arguello L, Bastida G et al. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. Dig Dis Sci 2004 49 : 931 6.
43. Fallone CA, Guyatt GH, Armstrong D et al. Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease Aliment Pharmacol Ther 2004 20 : 1161 9.
44. McColl E, Junghard O, Wiklund I et al. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients Am J Gastroenterol 2005 100 : 11 8.
45. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998 33 : 1023 9.
46. Crawley JA, Schmitt CM. How satisfied are chronic heartburn sufferers with their prescription medications? Results of the Patient Unmet Needs Survey. J Clin Outcomes Manag 2000 7 : 29 34.
47. Degl' Innocenti A, Guyatt GH, Wiklund I et al. The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Health Qual Life Outcomes 2005 3 : 4.
48. Shikiar R, Flood E, Siddique R et al. Development and validation of the gastroesophageal reflux disease treatment satisfaction questionnaire. Dig Dis Sci 2005 50 : 2025 33.
49. Armstrong D, Veldhuyzen van Zanten SJ, Chung SA et al. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. Can J Gastroenterol 2005 19 : 350 8.